Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Progress in Neurobiology|July 15, 2009
Somatostatin, Alzheimer's disease and cognition: an old story coming of age?Jacques Epelbaum, Jean-Louis Guillou, François Gastambide, et al.
Journal of Dental Biomechanics|August 28, 2012
Finite element analysis of adhesive endo-crowns of molars at different height levels of buccally applied loadIstabrak Hasan, Matthias Frentzen, Karl-Heinz Utz, et al.
Scientific Reports|June 8, 2023
Explaining population booms and busts in Mid-Holocene EuropeDániel Kondor, James S Bennett, Detlef Gronenborn, et al.
Psychopharmacology|January 11, 2017
Blunted 5-HT1A receptor-mediated responses and antidepressant-like behavior in mice lacking the GABAB1a but not GABAB1b subunit isoformsLaura H Jacobson, Daniel Hoyer, Dominique Fehlmann, et al.
Pharmacological Reviews|June 20, 2024
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and PharmacologyJyrki P Kukkonen, Laura H Jacobson, Daniel Hoyer, et al.
Journal of Cardiovascular Electrophysiology|September 28, 2023
Effectiveness of conduction system pacing for cardiac resynchronization therapy: A systematic review and network meta-analysisHamed Tavolinejad, Sina Kazemian, Ali Bozorgi, et al.
Chemistry & Biodiversity|July 24, 2008
The enantiomer of octreotate binds to all five somatostatin receptors with almost equal micromolar affinity--a comparison with SANDOSTATINJames Gardiner, Daniel Langenegger, Daniel Hoyer, et al.
Neuropharmacology|February 8, 2005
Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cellsDominik Feuerbach, Kurt Lingenhöhl, Peter Dobbins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 19, 2008
Antidepressants influence somatostatin levels and receptor pharmacology in brainEleftherios Pallis, Anna Vasilaki, Dominique Fehlmann, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonistsThomas Troxler, Konstanze Hurth, Karl-Heinrich Schuh, et al.
Pageof 15